会议专题

Environmental Responsibility and Biopharmaceutical Companies: Developing a Competitive Strategy

Corporate environmental responsibility (CER) is now on the corporate and political agenda in China. The objective of this study is to determine the relevance of environmental aspects for China biopharmaceutical companies. This paper presents a new perspective which calls for an integration of CER into the business strategy as a source of competitive advantages in the biopharmaceutical companies. We also introduce an Internal Responsibility System (IRS) to meet company’s environmental responsibilities.

CER Competitivestrategy Biopharmaceuticalcompanies IRS

Wei Li Ruixiang Yu

School of Economy and ManagementChina University of GeosciencesWuhan, China, 430074

国际会议

2011 International Conference on Business Management and Electronic Information(2011商业管理与电子信息国际学术会议 BMEI2011)

广州

英文

1-4

2011-05-13(万方平台首次上网日期,不代表论文的发表时间)